VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2021 | Real-world use of nivolumab in gastric cancer

Yu Sunakawa, MD, PhD, St. Marianna University School of Medicine, Kawasaki, Japan, discusses the findings of a prospective investigation evaluating clinical outcomes from real-world data of nivolumab treatment in advanced gastric cancer. The real-world data of nivolumab treatment in advanced gastric cancer indicated comparable survival to previous clinical trial data. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Disclosures

Yu Sunakawa, MD, PhD has received grants and personal fees from Taiho Pharmaceutical, Chugai Pharma, Takeda, Eli Lilly Japan, and Sanofi; personal fees from Bayer Yakuhin, Yakult Honsha, Bristol-Myers Squibb Japan, Merck Biopharma, Ono Pharma, MSD, Daiichi Sankyo; and grants from Otsuka.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter